Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Progenitor Cell
96%
Myocardial Infarction
74%
Cell Therapy
71%
Macrophage
70%
Percutaneous Aortic Valve Replacement
64%
Anticoagulation
64%
Left Coronary Artery
64%
Acute Heart Infarction
64%
Mononuclear Cell
64%
Oral
64%
Anticoagulant Therapy
61%
Adventitia
59%
Thromboembolism
50%
Cardiovascular System
49%
Coronary Artery Disease
47%
Infarction
42%
Brain Ischemia
42%
Quantitative Coronary Angiography
41%
Hematopoietic Cell
37%
Stem Cell
36%
Cell Transplantation
36%
Retrospective Study
36%
Thrombus
35%
Atherosclerosis
35%
Midodrine
32%
Vasa Vasorum
32%
End Stage Renal Disease
32%
Optical Coherence Tomography
32%
Hemodialysis
32%
Contraindication
32%
Public Health
32%
Patient with Hemophilia
32%
Conception
32%
Myocardial Bridge
32%
Muscle Resection
32%
Intravascular Ultrasound
32%
Ryanodine Receptor 2
32%
Medical Examiner
32%
Heart Left Ventricle Function
32%
Acute Coronary Syndrome
32%
Predictive Factor
32%
Heart Ventricle Remodeling
32%
Mesenchymal Stem Cell
32%
Cardiac Muscle Cell
32%
Scar Formation
32%
Pluripotent Stem Cell
32%
Uric Acid
32%
Stem Cell Therapy
32%
Heart Valve Prosthesis
32%
Immunology and Microbiology
Macrophage
41%
Immunoglobulin M
40%
Hematopoietic Cell
37%
Stem Cell
36%
Atherosclerosis
35%
Adventitia
35%
Blood Pressure
32%
Particulate Matter
32%
Coronary Artery Blood Flow
32%
Blood Level
32%
Immunotherapy
32%
Carcinoembryonic Antigen
32%
Blood Group Lewis System
32%
Phosphatase
32%
Colorectal Carcinoma
32%
CD14
32%
Mesenchymal Stem Cell
32%
Vascularization
32%
Colon
32%
Titer
29%
Radiofrequency
21%
Stem Cell Antigen 1
19%
Antiganglioside Antibodies
18%
Colony Forming Unit M
15%
Lineages
12%
Optical Density
11%
Diastolic Blood Pressure
10%
Systolic Blood Pressure
10%
Adjuvant
10%
Antibody Titer
10%
Antibody Response
10%
Precursor
9%
Apolipoprotein E Knockout Mouse
9%
Cell Line
8%
Tumor Cell
8%
Active Immunotherapy
8%
Cell Count
8%
Cell Suspension
8%
Coronary Sinus
8%
Pancreatic Carcinoma Cell Line
8%
Left Coronary Artery
8%
Ganglioside Antibody
8%
Carcinoma Cell
8%
Overall Survival
8%
Normal Human
8%
Mononuclear Cell
8%
Cell Surface
8%
Carbohydrate Antigen
8%
Myeloid
8%
Mediator
8%
Nursing and Health Professions
Percutaneous Coronary Intervention
88%
Contraindication
32%
Anticoagulant Therapy
32%
Anticoagulation
32%
Remission
32%
Tumor Necrosis Factor Inhibitor
32%
Psoriatic Arthritis
32%
Gamma Irradiation
32%
Tissue Injury
32%
Low Drug Dose
32%
Obstructive Lung Disease
32%
Aortic Valve Replacement
32%
Aortic Stenosis
32%
Acute Heart Infarction
32%
ST Segment Elevation Myocardial Infarction
32%
Placebo
32%
Infarction
24%
Heart Left Ventricle Ejection Fraction
24%
Charlson Comorbidity Index
19%
Instrument Sterilization
18%
Body Mass
16%
Health Assessment Questionnaire
16%
Clinical Disease Activity Index
16%
Cell Therapy
16%
Congestive Heart Failure
13%
Disease Activity
12%
Heart Infarction
12%
Atrial Fibrillation
11%
Medical Record
10%
Heart Death
10%
Haematoxylin
9%
Eosin
9%
Brain Ischemia
8%
Intracoronary Drug Administration
8%
Treatment Group
8%
Cardiovascular Disease
8%
National Health Organization
8%
Cardiovascular Magnetic Resonance
8%
Heart Left Ventricle Volume
8%
Adverse Event
8%
Reperfusion
8%
Heart Left Ventricle Failure
8%
Heart Ejection Fraction
6%
Proportional Hazards Model
6%
All Cause Mortality
6%
Thromboembolism
5%
Cerebrovascular Accident
5%
Bleeding
5%